2

Remote Biotech Investor Relations Jobs (NOW HIRING)

Fully Remote * Engagement Type: Independent Contractor * Projects may be extended, shortened, or concluded early depending on project requirements and performance. * Payments are made weekly based on ...

Head of Investor Relations

Salem, OR ยท On-site +1

$191K - $297K/yr

About the Role The Head of Investor Relations will lead the development and execution of the ... This is a fully remote role with the option to work hybrid if a commutable distance from our Salem ...

We are seeking an Investor Relations Analyst with exceptional communication and interpersonal ... Remote-first work environment (must live in the United States) * Competitive medical, dental, and ...

next page

Showing results 1-20

Remote Biotech Investor Relations information

See salary details

$31K

$101.1K

$191K

How much do remote biotech investor relations jobs pay per year?

As of Sep 7, 2026, the average yearly pay for remote biotech investor relations in the United States is $101,099.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $134,500.00 per year, depending on experience, location, and employer.

What is a remote biotech investor relations professional?

Remote Biotech Investor Relations professionals are specialists who manage communication between biotechnology companies and their investors while working from a remote location. They provide updates on company performance, scientific developments, and financial results, ensuring transparency and trust with stakeholders. Their role is crucial in maintaining investor confidence, addressing inquiries, and organizing virtual meetings or presentations to keep investors informed. By working remotely, they leverage digital tools to perform these tasks efficiently without being physically present at company headquarters.

What skills and qualifications are needed to thrive as a remote biotech investor relations professional?

To thrive as a Remote Biotech Investor Relations professional, you need a solid understanding of financial markets, biotechnology concepts, and strong communication skills, often backed by a degree in finance, life sciences, or business. Familiarity with investor relations management platforms, financial analysis tools, and compliance regulations is typically required. Exceptional interpersonal skills, strategic thinking, and the ability to convey complex scientific information in accessible terms help you stand out in this role. These capabilities are crucial for effectively building trust with investors, communicating company value, and supporting strategic business growth in a competitive industry.

What are the main challenges faced by remote biotech investor relations professionals, and how can they overcome them?

Remote biotech investor relations professionals often face challenges such as maintaining strong relationships with investors without in-person meetings and staying updated on complex scientific developments. To overcome these, they leverage video conferencing, regular digital updates, and concise, clear communication to keep stakeholders informed and engaged. Collaborating closely with internal scientific teams and executive leadership is crucial to ensure accurate, current messaging. Building a proactive approach to digital networking and timely responses can also strengthen trust and rapport with investors.

What is the difference between Remote Biotech Investor Relations vs Remote Biotech Medical Communications?

AspectRemote Biotech Investor RelationsRemote Biotech Medical Communications
Primary FocusManaging investor relationships, financial communication, and funding strategiesCommunicating scientific and medical information to healthcare professionals and patients
Required CredentialsFinance, business, or biotech background; investor relations experienceMedical, scientific, or healthcare communication background; scientific writing skills
Work EnvironmentCorporate, finance, or biotech firms; investor meetingsMedical agencies, biotech firms, or healthcare organizations; scientific conferences
Industry UsageCommon in publicly traded biotech companies seeking fundingCommon in biotech and pharmaceutical companies focusing on medical education

Remote Biotech Investor Relations and Remote Biotech Medical Communications differ mainly in their focus: investor relations centers on financial and funding communication, while medical communications emphasizes scientific and medical information dissemination. Both roles require specialized knowledge but serve distinct audiences within the biotech industry.

More about Remote Biotech Investor Relations jobs

What cities are hiring for Remote Biotech Investor Relations jobs?

Cities with the most Remote Biotech Investor Relations job openings:

What are the most commonly searched types of Biotech Investor Relations jobs?

The most popular types of Biotech Investor Relations jobs are:

What states have the most Remote Biotech Investor Relations jobs?

States with the most job openings for Remote Biotech Investor Relations jobs include:

Infographic showing various Remote Biotech Investor Relations job openings in the United States as of August 2026, with employment types broken down into 1% As Needed, 85% Full Time, 12% Part Time, 1% Temporary, and 1% Contract. Highlights an 94% Physical, 2% Hybrid, and 4% Remote job distribution, with an average salary of $101,099 per year, or $48.6 per hour.

Director, Investor Relations & Communications

Peptilogics

Pittsburgh, PA โ€ข On-site, Remote

Full-time

Re-posted yesterday


Job description

Position Overview

The Director, Investor Relations & Communications leads all external communications tied to Peptilogics' corporate narrative, investor engagement, and public positioning. This individual is the key point of contact for current and prospective investors, analysts, and media, ensuring consistent, transparent, and compelling messaging across every channel, and also supports strategic internal communications and cross-functional alignment around value-creating milestones. Reporting to the COO (CFO once hired), the role collaborates closely with Finance, Clinical, Regulatory, and Corporate Operations to shape disclosures, presentations, and communications strategy. The ideal candidate brings deep life-sciences IR experience, thrives in a fast-paced, high-stakes environment, and can build a compelling narrative for a category-defining asset where there may be no clear analogs of success, building the investor infrastructure and external positioning needed to support future raises and long-term market shaping.

Essential Functions

  • Develop and execute Peptilogics' investor-relations strategy, including calendar planning, proactive outreach, content creation, and engagement tracking
  • Serve as primary point of contact for current and prospective investors, analysts, and relevant media
  • Own development and maintenance of all IR materials, investor decks, fact sheets, financing announcements, press releases, and Q&A documents
  • Manage public-facing channels, including the corporate website and social platforms, ensuring timely, accurate, compliant, and consistent messaging
  • Coordinate investor and analyst engagement across conferences, non-deal roadshows, and industry events
  • Lead message development for key milestones, clinical readouts, regulatory updates, financings, grant awards, and commercial progress
  • Track and report investor sentiment, sector trends, competition, and peer communications to inform executive decisions and positioning
  • Manage IR/PR agency relationships to support execution, visibility, and crisis response
  • Prepare executives for investor meetings, speaking engagements, and media with tailored briefings and coaching
  • Operationalize a recurring investor-update cadence (quarterly reports, post-Board updates, ad hoc news flow) and translate internal insights into investor-facing narrative
  • Partner with Clinical, Regulatory, CMC, Legal, and Finance to ensure technical accuracy, compliance, and alignment in public-facing documents
  • Support internal communications and collaborate with Corporate Operations for consistency across internal and external messaging
  • Contribute to Board materials and corporate reporting tied to strategic communications and investor engagement
  • Support presence at scientific conferences, trade shows, and investor events; contribute to pre-commercial positioning as programs advance
  • Perform other duties as assigned

Required Qualifications and Skills

  • Exceptional written and verbal communication, with the ability to translate complex scientific and financial information into clear, compelling messaging
  • Proven ability to lead IR strategy and manage buy- and sell-side relationships in biotech or life sciences
  • Deep understanding of the pre-commercial biotech landscape, capital markets, development milestones, and regulatory communications
  • Strong organizational and project-management skills against tight, high-stakes deadlines
  • Sound, independent judgment in a fast-paced, dynamic environment
  • Comfort serving as a public-facing representative across external communications and events
  • Discretion and professionalism with sensitive or confidential information
  • Bachelor's degree required; advanced degree (MBA, MS, or equivalent) in life sciences, finance, or communications strongly preferred
  • 8-12 years in investor relations, corporate communications, or strategic finance within biotech, pharma, orthopedics, or healthcare
  • Demonstrated experience supporting or leading investor communications at a pre- or early-commercial life-sciences company
  • Experience coordinating across Clinical, Regulatory, Legal, and Finance for compliant, accurate external messaging

Desirable Qualifications and Skills

  • Orthopedic and MedTech market experience
  • Experience overseeing corporate websites and social channels for investor/reputational communications
  • Familiarity with SEC regulations and disclosure practices relevant to private and public biotech
  • Direct experience with PR/IR agencies and cross-channel campaigns
  • Background in financial analysis or capital markets; ability to interpret market sentiment and peer performance
  • Prior involvement in crossover rounds, IPO positioning, or strategic partnerships